Biogen Inc. (ETR:IDP)
149.15
+1.00 (0.67%)
Dec 22, 2025, 5:35 PM CET
Biogen Market Cap
Biogen has a market cap or net worth of €21.8 billion as of December 22, 2025. Its market cap has decreased by -2.11% in one year.
Market Cap
21.80B
Enterprise Value
24.03B
Revenue
8.58B
Ranking
n/a
PE Ratio
15.90
Stock Price
€149.15
Market Cap Chart
Since September 17, 1991, Biogen's market cap has increased from 126.71M to 21.80B, an increase of 17,101.93%. That is a compound annual growth rate of 16.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 21.88B | 1.68% |
| Dec 31, 2024 | 21.52B | -36.55% |
| Dec 29, 2023 | 33.92B | -9.09% |
| Dec 30, 2022 | 37.31B | 20.41% |
| Dec 31, 2021 | 30.99B | 0.60% |
| Dec 31, 2020 | 30.80B | -35.44% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 51.87B |
| Siemens Healthineers AG | 49.92B |
| Bayer Aktiengesellschaft | 34.92B |
| Fresenius SE & Co. KGaA | 27.35B |
| Sartorius Aktiengesellschaft | 14.95B |
| Fresenius Medical Care AG | 11.63B |
| Fielmann Group AG | 3.62B |
| Carl Zeiss Meditec AG | 3.52B |